NCT00573430View on ClinicalTrials.gov

ARIA (Atacand Renoprotection In NephropAthy Pt.)

PHASE4CompletedINTERVENTIONAL

Enrollment

128

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

August 31, 2009

Study Completion Date

August 31, 2009

Conditions

Non-diabetic Nephropathy With Hypertension

Interventions

DRUG

Candesartan Cilexetil

8 mg oral once daily dose

DRUG

Candesartan Cilexetil

16 mg oral once daily dose

DRUG

Candesartan Cilexetil 32mg

32 mg oral once daily dose

Trial Locations (1)

Unknown

Research Site, Seoul

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY